RAI2 and prostate cancer: RAI2, a recently recognized tumour suppressor, is believed to have major parts in the progression and metastasis of quite a few of malignancies including breast cancer [8, 31], colorectal cancer [7, 32], bladder cancer [10], and prostate cancer [33].